Neogen (FRA:NG2) Current Accrued Expense : €26.2 Mil (As of Feb. 2024)

View and export this data going back to 1989. Start your Free Trial

What is Neogen Current Accrued Expense?

Neogen's Current Accrued Expense for the quarter that ended in Feb. 2024 was €26.2 Mil.

Neogen's quarterly Current Accrued Expense increased from Aug. 2023 (€19.5 Mil) to Nov. 2023 (€28.9 Mil) but then declined from Nov. 2023 (€28.9 Mil) to Feb. 2024 (€26.2 Mil).

Neogen's annual Current Accrued Expense increased from May. 2021 (€10.9 Mil) to May. 2022 (€23.2 Mil) and increased from May. 2022 (€23.2 Mil) to May. 2023 (€29.5 Mil).

Neogen Current Accrued Expense Historical Data

The historical data trend for Neogen's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neogen Current Accrued Expense Chart

Neogen Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

May21

May22

May23

Current Accrued Expense

Get a 7-Day Free Trial

10.28

12.52

10.86

23.20

29.52

Neogen Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Current Accrued Expense	Get a 7-Day Free Trial															19.49	29.52	19.47	28.94	26.15

Neogen Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Neogen Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Neogen's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Neogen (FRA:NG2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Neogen Corp (FRA:NG2) » Definitions » Current Accrued Expense

Comparable Companies

GH SHC TWST NEO RDNT MYGN VCYT LAB OPK FLGT TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT

Traded in Other Exchanges

NEOG:USA NG2:Germany

Address

620 Lesher Place, Lansing, MI, USA, 48912

Website

https://www.neogen.com

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety (70% of post-merger sales), Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety (20% of post-merger sales), Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for 60% of total revenue, while international markets, including Canada, Europe, Asia, and Latin America, account for the remaining 40%.

Neogen (FRA:NG2) Headlines

No Headlines